Cargando…

Cereset Research Standard Operating Procedures for Insomnia: A Randomized, Controlled Clinical Trial

BACKGROUND: Interventions for insomnia that also address autonomic dysfunction are needed. OBJECTIVE: We evaluate Cereset Research™ Standard Operating Procedures (CR-SOP) in a pilot randomized, controlled trial. CR-SOP is a less operator-dependent, more generalizable innovation of HIRREM(®), a nonin...

Descripción completa

Detalles Bibliográficos
Autores principales: Tegeler, Catherine L., Munger Clary, Heidi, Shaltout, Hossam A., Simpson, Sean L., Gerdes, Lee, Tegeler, Charles H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9933987/
https://www.ncbi.nlm.nih.gov/pubmed/36816469
http://dx.doi.org/10.1177/27536130221147475
_version_ 1784889785620365312
author Tegeler, Catherine L.
Munger Clary, Heidi
Shaltout, Hossam A.
Simpson, Sean L.
Gerdes, Lee
Tegeler, Charles H.
author_facet Tegeler, Catherine L.
Munger Clary, Heidi
Shaltout, Hossam A.
Simpson, Sean L.
Gerdes, Lee
Tegeler, Charles H.
author_sort Tegeler, Catherine L.
collection PubMed
description BACKGROUND: Interventions for insomnia that also address autonomic dysfunction are needed. OBJECTIVE: We evaluate Cereset Research™ Standard Operating Procedures (CR-SOP) in a pilot randomized, controlled trial. CR-SOP is a less operator-dependent, more generalizable innovation of HIRREM(®), a noninvasive, closed-loop, allostatic, acoustic stimulation neurotechnology demonstrated to improve insomnia and autonomic function. METHODS: Adults with Insomnia Severity Index (ISI) scores of ≥8 were randomized to receive ten sessions of CR-SOP, with tones linked to brainwaves (LB, intervention), or a sham condition of random tones not linked to brainwaves (NL, control). Measures were collected at enrollment and 0-14 days and 4-6 weeks post-allocated intervention. The primary outcome was differential change in ISI from baseline to 4-6 weeks post-intervention. Secondary self-report measures assessed sleep quality65 and behavioral outcomes. Ten-minute recordings of heart rate and blood pressure were collected to analyze autonomic function (heart rate variability [HRV] and baroreflex sensitivity). RESULTS: Of 22 randomized, 20 participants completed the allocated condition. Intention to treat analysis of change from baseline to the 4-6 week outcome demonstrated mean ISI score reduction of 4.69 points among controls (SE 1.40). In the intervention group, there was an additional 2.58 point reduction in ISI score (SE 2.13; total reduction of 7.27, P = .24). Sleep quality and some measures of autonomic function improved significantly among the intervention group compared to control. CONCLUSIONS: This pilot study compared use of a standardized, allostatic, acoustic neurotechnology intervention with a sham, active control condition. The magnitude of change in insomnia severity was clinically relevant and similar to the findings in a prior, fully powered trial, but the differential improvement observed was not statistically significant. Significant improvements were demonstrated in sleep quality and some autonomic function measures.
format Online
Article
Text
id pubmed-9933987
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-99339872023-02-17 Cereset Research Standard Operating Procedures for Insomnia: A Randomized, Controlled Clinical Trial Tegeler, Catherine L. Munger Clary, Heidi Shaltout, Hossam A. Simpson, Sean L. Gerdes, Lee Tegeler, Charles H. Glob Adv Integr Med Health Original Article BACKGROUND: Interventions for insomnia that also address autonomic dysfunction are needed. OBJECTIVE: We evaluate Cereset Research™ Standard Operating Procedures (CR-SOP) in a pilot randomized, controlled trial. CR-SOP is a less operator-dependent, more generalizable innovation of HIRREM(®), a noninvasive, closed-loop, allostatic, acoustic stimulation neurotechnology demonstrated to improve insomnia and autonomic function. METHODS: Adults with Insomnia Severity Index (ISI) scores of ≥8 were randomized to receive ten sessions of CR-SOP, with tones linked to brainwaves (LB, intervention), or a sham condition of random tones not linked to brainwaves (NL, control). Measures were collected at enrollment and 0-14 days and 4-6 weeks post-allocated intervention. The primary outcome was differential change in ISI from baseline to 4-6 weeks post-intervention. Secondary self-report measures assessed sleep quality65 and behavioral outcomes. Ten-minute recordings of heart rate and blood pressure were collected to analyze autonomic function (heart rate variability [HRV] and baroreflex sensitivity). RESULTS: Of 22 randomized, 20 participants completed the allocated condition. Intention to treat analysis of change from baseline to the 4-6 week outcome demonstrated mean ISI score reduction of 4.69 points among controls (SE 1.40). In the intervention group, there was an additional 2.58 point reduction in ISI score (SE 2.13; total reduction of 7.27, P = .24). Sleep quality and some measures of autonomic function improved significantly among the intervention group compared to control. CONCLUSIONS: This pilot study compared use of a standardized, allostatic, acoustic neurotechnology intervention with a sham, active control condition. The magnitude of change in insomnia severity was clinically relevant and similar to the findings in a prior, fully powered trial, but the differential improvement observed was not statistically significant. Significant improvements were demonstrated in sleep quality and some autonomic function measures. SAGE Publications 2023-01-18 /pmc/articles/PMC9933987/ /pubmed/36816469 http://dx.doi.org/10.1177/27536130221147475 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Article
Tegeler, Catherine L.
Munger Clary, Heidi
Shaltout, Hossam A.
Simpson, Sean L.
Gerdes, Lee
Tegeler, Charles H.
Cereset Research Standard Operating Procedures for Insomnia: A Randomized, Controlled Clinical Trial
title Cereset Research Standard Operating Procedures for Insomnia: A Randomized, Controlled Clinical Trial
title_full Cereset Research Standard Operating Procedures for Insomnia: A Randomized, Controlled Clinical Trial
title_fullStr Cereset Research Standard Operating Procedures for Insomnia: A Randomized, Controlled Clinical Trial
title_full_unstemmed Cereset Research Standard Operating Procedures for Insomnia: A Randomized, Controlled Clinical Trial
title_short Cereset Research Standard Operating Procedures for Insomnia: A Randomized, Controlled Clinical Trial
title_sort cereset research standard operating procedures for insomnia: a randomized, controlled clinical trial
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9933987/
https://www.ncbi.nlm.nih.gov/pubmed/36816469
http://dx.doi.org/10.1177/27536130221147475
work_keys_str_mv AT tegelercatherinel ceresetresearchstandardoperatingproceduresforinsomniaarandomizedcontrolledclinicaltrial
AT mungerclaryheidi ceresetresearchstandardoperatingproceduresforinsomniaarandomizedcontrolledclinicaltrial
AT shaltouthossama ceresetresearchstandardoperatingproceduresforinsomniaarandomizedcontrolledclinicaltrial
AT simpsonseanl ceresetresearchstandardoperatingproceduresforinsomniaarandomizedcontrolledclinicaltrial
AT gerdeslee ceresetresearchstandardoperatingproceduresforinsomniaarandomizedcontrolledclinicaltrial
AT tegelercharlesh ceresetresearchstandardoperatingproceduresforinsomniaarandomizedcontrolledclinicaltrial